{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T03:57:56Z","timestamp":1794887876037,"version":"4.9.1"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T00:00:00Z","timestamp":1745020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T00:00:00Z","timestamp":1745020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"SWISS GOVERNMENT EXCELLENCE SCHOLARSHIP","award":["2022.0470"],"award-info":[{"award-number":["2022.0470"]}]},{"name":"SWISS GOVERNMENT EXCELLENCE SCHOLARSHIP","award":["2023.0011"],"award-info":[{"award-number":["2023.0011"]}]},{"name":"Marie Sk\u0142odowska-Curie Individual Fellowship","award":["101023999"],"award-info":[{"award-number":["101023999"]}]},{"name":"CANCER RESEARCH SWITZERLAND","award":["KFS-5557-02-2022"],"award-info":[{"award-number":["KFS-5557-02-2022"]}]},{"DOI":"10.13039\/501100007282","name":"UniBern Forschungsstiftung","doi-asserted-by":"publisher","award":["2024_37"],"award-info":[{"award-number":["2024_37"]}],"id":[{"id":"10.13039\/501100007282","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Endogenous androgens are pivotal in the development and progression of prostate cancer (PC). We investigated nanoparticle formulations of curcumin and piperine in modulating steroidogenesis within PC cells. Using multiple PC cell lines (LNCaP, VCaP, DU145 and PC3) we studied the effects of curcumin, piperine, and their nanoparticle formulations\u2014curcumin nanoparticles, piperine nanoparticles, and curcumin\u2013piperine nanoparticles (CPN)\u2014on cell viability, migration, and steroid biosynthesis. Curcumin and its nanoparticle formulations significantly reduced cell viability in PC cells, with curcumin\u2013piperine nanoparticles showing the highest efficacy. These treatments also inhibited cell migration, with CPN exhibiting the most pronounced effect. In assays for steroid biosynthesis, curcumin, and its nanoparticle formulations, as well as piperine and its nanoparticles, selectively inhibited 17\u03b1-hydroxylase and 17,20-lyase activities of cytochrome P450 17A1 (CYP17A1). Abiraterone, a CYP17A1 inhibitor, displayed a broader inhibition of steroid metabolism including cytochrome P450 21-hydroxylase activity, whereas curcumin and piperine provided a more targeted inhibition profile. Analysis of steroid metabolites by liquid chromatography-mass spectrometry revealed that CPN caused significant reduction of androstenedione and cortisol, suggesting potential synergistic effects. In conclusion, nanoformulations co-loaded with curcumin and piperine offer an effective approach to targeting steroidogenesis and could be promising candidates for therapies aimed at managing androgen-dependent PC.<\/jats:p>","DOI":"10.1038\/s41598-025-98102-z","type":"journal-article","created":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T12:56:02Z","timestamp":1745067362000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Nanoparticles with curcumin and piperine modulate steroid biosynthesis in prostate cancer"],"prefix":"10.1038","volume":"15","author":[{"given":"Jibira","family":"Yakubu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos","family":"Natsaridis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therina","family":"du Toit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel Sousa","family":"Barata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oya","family":"Tagit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit V.","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,19]]},"reference":[{"key":"98102_CR1","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/S0140-6736(14)61947-4","volume":"387","author":"G Attard","year":"2016","unstructured":"Attard, G. et al. Prostate cancer. Lancet 387, 70\u201382.\u00a0https:\/\/doi.org\/10.1016\/s0140-6736(14)61947-4 (2016).","journal-title":"Lancet"},{"key":"98102_CR2","doi-asserted-by":"publisher","first-page":"457","DOI":"10.2147\/rru.s264722","volume":"13","author":"F Crowley","year":"2021","unstructured":"Crowley, F. et al. A review of the pathophysiological mechanisms underlying castration-resistant prostate cancer. Res. Rep. Urol. 13, 457\u2013472. https:\/\/doi.org\/10.2147\/rru.s264722 (2021).","journal-title":"Res. Rep. Urol."},{"key":"98102_CR3","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3390\/medicina60010077","volume":"60","author":"AB Reiss","year":"2023","unstructured":"Reiss, A. B. et al. Androgen deprivation therapy for prostate cancer: Focus on cognitive function and mood. Medicina 60, 77. https:\/\/doi.org\/10.3390\/medicina60010077 (2023).","journal-title":"Medicina"},{"key":"98102_CR4","doi-asserted-by":"publisher","first-page":"100733","DOI":"10.1016\/j.ctro.2024.100733","volume":"45","author":"A Gomez-Iturriaga","year":"2024","unstructured":"Gomez-Iturriaga, A., B\u00fcchser, D., Lopez-Campos, F. & Maldonado, X. Enhancing androgen deprivation therapy (ADT) integration in prostate cancer: Insights for Stereotactic Body Radiotherapy (SBRT) and brachytherapy modalities. Clin. Transl. Radiat. Oncol. 45, 100733. https:\/\/doi.org\/10.1016\/j.ctro.2024.100733 (2024).","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"98102_CR5","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/s1470-2045(21)00705-1","volume":"23","author":"AU Kishan","year":"2022","unstructured":"Kishan, A. U. et al. Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: An individual patient data meta-analysis. Lancet Oncol. 23, 304\u2013316. https:\/\/doi.org\/10.1016\/s1470-2045(21)00705-1 (2022).","journal-title":"Lancet Oncol."},{"key":"98102_CR6","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.eururo.2019.08.005","volume":"77","author":"MB Culp","year":"2020","unstructured":"Culp, M. B., Soerjomataram, I., Efstathiou, J. A., Bray, F. & Jemal, A. Recent global patterns in prostate cancer incidence and mortality rates. Eur. Urol. 77, 38\u201352. https:\/\/doi.org\/10.1016\/j.eururo.2019.08.005 (2020).","journal-title":"Eur. Urol."},{"key":"98102_CR7","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1210\/er.2010-0013","volume":"32","author":"WL Miller","year":"2011","unstructured":"Miller, W. L. & Auchus, R. J. The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr. Rev. 32, 81\u2013151. https:\/\/doi.org\/10.1210\/er.2010-0013 (2011).","journal-title":"Endocr. Rev."},{"key":"98102_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/ph11020037","author":"M Fernandez-Cancio","year":"2018","unstructured":"Fernandez-Cancio, M. et al. Mechanism of the dual activities of human CYP17A1 and binding to anti-prostate cancer drug abiraterone revealed by a novel V366M mutation causing 17,20 lyase deficiency. Pharmaceuticals 11, 37. https:\/\/doi.org\/10.3390\/ph11020037 (2018).","journal-title":"Pharmaceuticals"},{"key":"98102_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/biom12020165","author":"TM Wrobel","year":"2022","unstructured":"Wrobel, T. M. et al. Synthesis and structure\u2013activity relationships of novel non-steroidal CYP17A1 inhibitors as potential prostate cancer agents. Biomolecules 12, 165. https:\/\/doi.org\/10.3390\/biom12020165 (2022).","journal-title":"Biomolecules"},{"key":"98102_CR10","doi-asserted-by":"publisher","first-page":"5047","DOI":"10.3390\/cancers15205047","volume":"15","author":"TK Le","year":"2023","unstructured":"Le, T. K. et al. Castration-resistant prostate cancer: From uncovered resistance mechanisms to current treatments. Cancers 15, 5047. https:\/\/doi.org\/10.3390\/cancers15205047 (2023).","journal-title":"Cancers"},{"key":"98102_CR11","doi-asserted-by":"publisher","first-page":"6542","DOI":"10.1021\/acs.jmedchem.3c00442","volume":"66","author":"TM Wr\u00f3bel","year":"2023","unstructured":"Wr\u00f3bel, T. M. et al. Non-steroidal CYP17A1 inhibitors: Discovery and assessment. J. Med. Chem. 66, 6542\u20136566. https:\/\/doi.org\/10.1021\/acs.jmedchem.3c00442 (2023).","journal-title":"J. Med. Chem."},{"key":"98102_CR12","doi-asserted-by":"publisher","first-page":"637","DOI":"10.3390\/pharmaceutics16050637","volume":"16","author":"J Yakubu","year":"2024","unstructured":"Yakubu, J. & Pandey, A. V. Innovative delivery systems for curcumin: Exploring nanosized and conventional formulations. Pharmaceutics 16, 637.\u00a0https:\/\/doi.org\/10.3390\/pharmaceutics16050637 (2024).","journal-title":"Pharmaceutics"},{"key":"98102_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20184606","author":"P Rodr\u00edguez Casta\u00f1o","year":"2019","unstructured":"Rodr\u00edguez Casta\u00f1o, P., Parween, S. & Pandey, A. V. Bioactivity of curcumin on the cytochrome P450 enzymes of the steroidogenic pathway. Int. J. Mol. Sci. 20, 4606. https:\/\/doi.org\/10.3390\/ijms20184606 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"98102_CR14","doi-asserted-by":"publisher","first-page":"8635","DOI":"10.1016\/j.biomaterials.2014.06.040","volume":"35","author":"MM Yallapu","year":"2014","unstructured":"Yallapu, M. M. et al. Anti-cancer activity of curcumin loaded nanoparticles in prostate cancer. Biomaterials 35, 8635\u20138648. https:\/\/doi.org\/10.1016\/j.biomaterials.2014.06.040 (2014).","journal-title":"Biomaterials"},{"key":"98102_CR15","doi-asserted-by":"publisher","first-page":"10713","DOI":"10.1021\/acsomega.2c07326","volume":"8","author":"M Hegde","year":"2023","unstructured":"Hegde, M., Girisa, S., BharathwajChetty, B., Vishwa, R. & Kunnumakkara, A. B. Curcumin formulations for better bioavailability: What we learned from clinical trials thus far?. ACS Omega 8, 10713\u201310746. https:\/\/doi.org\/10.1021\/acsomega.2c07326 (2023).","journal-title":"ACS Omega"},{"key":"98102_CR16","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","volume":"161","author":"F Danhier","year":"2012","unstructured":"Danhier, F. et al. PLGA-based nanoparticles: An overview of biomedical applications. J. Control. Release 161, 505\u2013522. https:\/\/doi.org\/10.1016\/j.jconrel.2012.01.043 (2012).","journal-title":"J. Control. Release"},{"key":"98102_CR17","doi-asserted-by":"publisher","first-page":"102867","DOI":"10.1016\/j.jddst.2021.102867","volume":"66","author":"I Seko","year":"2021","unstructured":"Seko, I. et al. Development of curcumin and docetaxel co-loaded actively targeted PLGA nanoparticles to overcome blood brain barrier. J. Drug Deliv. Sci. Technol. 66, 102867. https:\/\/doi.org\/10.1016\/j.jddst.2021.102867 (2021).","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"98102_CR18","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S0168-3659(02)00212-2","volume":"83","author":"C Fonseca","year":"2002","unstructured":"Fonseca, C., Simoes, S. & Gaspar, R. Paclitaxel-loaded PLGA nanoparticles: Preparation, physicochemical characterization and in vitro anti-tumoral activity. J. Control. Release 83, 273\u2013286.\u00a0https:\/\/doi.org\/10.1016\/s0168-3659(02)00212-2 (2002).","journal-title":"J. Control. Release"},{"key":"98102_CR19","doi-asserted-by":"publisher","first-page":"120807","DOI":"10.1016\/j.ijpharm.2021.120807","volume":"605","author":"MC Operti","year":"2021","unstructured":"Operti, M. C. et al. PLGA-based nanomedicines manufacturing: Technologies overview and challenges in industrial scale-up. Int. J. Pharm. 605, 120807. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120807 (2021).","journal-title":"Int. J. Pharm."},{"key":"98102_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01260","author":"S Rezvantalab","year":"2018","unstructured":"Rezvantalab, S. et al. PLGA-based nanoparticles in cancer treatment. Front. Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2018.01260 (2018).","journal-title":"Front. Pharmacol."},{"key":"98102_CR21","doi-asserted-by":"publisher","first-page":"309","DOI":"10.2174\/1570159x19666210823103020","volume":"20","author":"SK Shahbaz","year":"2022","unstructured":"Shahbaz, S. K., Koushki, K., Sathyapalan, T., Majeed, M. & Sahebkar, A. PLGA-based curcumin delivery system: An interesting therapeutic approach in the treatment of Alzheimer\u2019s disease. Curr. Neuropharmacol. 20, 309\u2013323. https:\/\/doi.org\/10.2174\/1570159x19666210823103020 (2022).","journal-title":"Curr. Neuropharmacol."},{"key":"98102_CR22","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3390\/biom9020056","volume":"9","author":"M Del Prado-Audelo","year":"2019","unstructured":"Del Prado-Audelo, M. et al. Formulations of curcumin nanoparticles for brain diseases. Biomolecules 9, 56. https:\/\/doi.org\/10.3390\/biom9020056 (2019).","journal-title":"Biomolecules"},{"key":"98102_CR23","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1208\/s12248-015-9811-z","volume":"17","author":"MM Yallapu","year":"2015","unstructured":"Yallapu, M. M., Nagesh, P. K. B., Jaggi, M. & Chauhan, S. C. Therapeutic applications of curcumin nanoformulations. AAPS J. 17, 1341\u20131356. https:\/\/doi.org\/10.1208\/s12248-015-9811-z (2015).","journal-title":"AAPS J."},{"key":"98102_CR24","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.drudis.2011.09.009","volume":"17","author":"MM Yallapu","year":"2012","unstructured":"Yallapu, M. M., Jaggi, M. & Chauhan, S. C. Curcumin nanoformulations: A future nanomedicine for cancer. Drug Discov. Today 17, 71\u201380. https:\/\/doi.org\/10.1016\/j.drudis.2011.09.009 (2012).","journal-title":"Drug Discov. Today"},{"key":"98102_CR25","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jddst.2015.08.009","volume":"29","author":"M Pachauri","year":"2015","unstructured":"Pachauri, M., Gupta, E. D. & Ghosh, P. C. Piperine loaded PEG-PLGA nanoparticles: Preparation, characterization and targeted delivery for adjuvant breast cancer chemotherapy. J. Drug Deliv. Sci. Technol. 29, 269\u2013282. https:\/\/doi.org\/10.1016\/j.jddst.2015.08.009 (2015).","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"98102_CR26","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1002\/ptr.7737","volume":"37","author":"H Heidari","year":"2023","unstructured":"Heidari, H. et al. Curcumin\u2013piperine co-supplementation and human health: A comprehensive review of preclinical and clinical studies. Phytother. Res. 37, 1462\u20131487. https:\/\/doi.org\/10.1002\/ptr.7737 (2023).","journal-title":"Phytother. Res."},{"key":"98102_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1145666","author":"B Y\u00fcksel","year":"2023","unstructured":"Y\u00fcksel, B., H\u0131zl\u0131 Deniz, A. A., \u015eahin, F., Sahin, K. & T\u00fcrkel, N. Cannabinoid compounds in combination with curcumin and piperine display an anti-tumorigenic effect against colon cancer cells. Front. Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2023.1145666 (2023).","journal-title":"Front. Pharmacol."},{"key":"98102_CR28","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1055\/s-2006-957450","volume":"64","author":"G Shoba","year":"1998","unstructured":"Shoba, G. et al. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 64, 353\u2013356. https:\/\/doi.org\/10.1055\/s-2006-957450 (1998).","journal-title":"Planta Med."},{"key":"98102_CR29","doi-asserted-by":"publisher","first-page":"104624","DOI":"10.1016\/j.jddst.2023.104624","volume":"86","author":"F Ahmadi","year":"2023","unstructured":"Ahmadi, F. et al. Efficient synergistic combination effect of curcumin with piperine by polymeric magnetic nanoparticles for breast cancer treatment. J. Drug Deliv. Sci. Technol. 86, 104624. https:\/\/doi.org\/10.1016\/j.jddst.2023.104624 (2023).","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"98102_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2019.00206","author":"AS Abdul Manap","year":"2019","unstructured":"Abdul Manap, A. S. et al. synergistic effects of curcumin and piperine as potent acetylcholine and amyloidogenic inhibitors with significant neuroprotective activity in SH-SY5Y cells via computational molecular modeling and in vitro assay. Front. Aging Neurosci. 11, 206. https:\/\/doi.org\/10.3389\/fnagi.2019.00206 (2019).","journal-title":"Front. Aging Neurosci."},{"key":"98102_CR31","doi-asserted-by":"publisher","first-page":"38103","DOI":"10.1021\/acsami.9b11782","volume":"11","author":"S Chen","year":"2019","unstructured":"Chen, S. et al. Core-shell biopolymer nanoparticles for co-delivery of curcumin and piperine: sequential electrostatic deposition of hyaluronic acid and chitosan shells on the zein core. ACS Appl. Mater. Interfaces 11, 38103\u201338115. https:\/\/doi.org\/10.1021\/acsami.9b11782 (2019).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"98102_CR32","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1080\/03639045.2020.1820032","volume":"46","author":"H Abolhassani","year":"2020","unstructured":"Abolhassani, H., Safavi, M. S., Handali, S., Nosrati, M. & Shojaosadati, S. A. Synergistic effect of self-assembled curcumin and piperine co-loaded human serum albumin nanoparticles on suppressing cancer cells. Drug Dev. Ind. Pharm. 46, 1647\u20131655. https:\/\/doi.org\/10.1080\/03639045.2020.1820032 (2020).","journal-title":"Drug Dev. Ind. Pharm."},{"key":"98102_CR33","doi-asserted-by":"publisher","first-page":"112700","DOI":"10.1016\/j.fct.2021.112700","volume":"158","author":"CH Facina","year":"2021","unstructured":"Facina, C. H. et al. Protective effect of the association of curcumin with piperine on prostatic lesions: New perspectives on BPA-induced carcinogenesis. Food Chem. Toxicol. 158, 112700. https:\/\/doi.org\/10.1016\/j.fct.2021.112700 (2021).","journal-title":"Food Chem. Toxicol."},{"key":"98102_CR34","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1016\/j.foodchem.2013.04.125","volume":"141","author":"MT Do","year":"2013","unstructured":"Do, M. T. et al. Antitumor efficacy of piperine in the treatment of human HER2-overexpressing breast cancer cells. Food Chem. 141, 2591\u20132599. https:\/\/doi.org\/10.1016\/j.foodchem.2013.04.125 (2013).","journal-title":"Food Chem."},{"key":"98102_CR35","doi-asserted-by":"publisher","first-page":"747","DOI":"10.3390\/toxins12120747","volume":"12","author":"E Turrini","year":"2020","unstructured":"Turrini, E., Sestili, P. & Fimognari, C. Overview of the anticancer potential of the \u201cking of spices\u201d Piper nigrum and its main constituent piperine. Toxins 12, 747. https:\/\/doi.org\/10.3390\/toxins12120747 (2020).","journal-title":"Toxins"},{"key":"98102_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s13018-023-03642-7","author":"Y Qi","year":"2023","unstructured":"Qi, Y., Yao, L., Liu, J. & Wang, W. Piperine improves the sensitivity of osteosarcoma cells to doxorubicin by inducing apoptosis and inhibiting the PI3K\/AKT\/GSK-3\u03b2 pathway. J Orthop. Surg. Res. 18, 180. https:\/\/doi.org\/10.1186\/s13018-023-03642-7 (2023).","journal-title":"J Orthop. Surg. Res."},{"key":"98102_CR37","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jcis.2010.05.022","volume":"351","author":"MM Yallapu","year":"2010","unstructured":"Yallapu, M. M., Gupta, B. K., Jaggi, M. & Chauhan, S. C. Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells. J. Colloid Interface Sci. 351, 19\u201329. https:\/\/doi.org\/10.1016\/j.jcis.2010.05.022 (2010).","journal-title":"J. Colloid Interface Sci."},{"key":"98102_CR38","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.carbpol.2012.04.036","volume":"90","author":"J Liu","year":"2012","unstructured":"Liu, J. et al. Preparation and characterization of cationic curcumin nanoparticles for improvement of cellular uptake. Carbohyd. Polym. 90, 16\u201322. https:\/\/doi.org\/10.1016\/j.carbpol.2012.04.036 (2012).","journal-title":"Carbohyd. Polym."},{"key":"98102_CR39","doi-asserted-by":"publisher","first-page":"5823","DOI":"10.2147\/ijn.s171099","volume":"13","author":"BF Mogharbel","year":"2018","unstructured":"Mogharbel, B. F. et al. Fluorescence properties of curcumin-loaded nanoparticles for cell tracking. Int. J. Nanomed. 13, 5823\u20135836. https:\/\/doi.org\/10.2147\/ijn.s171099 (2018).","journal-title":"Int. J. Nanomed."},{"key":"98102_CR40","doi-asserted-by":"publisher","first-page":"122944","DOI":"10.1016\/j.ijpharm.2023.122944","volume":"639","author":"R Wang","year":"2023","unstructured":"Wang, R. et al. PLGA nanoparticles loaded with curcumin produced luminescence for cell bioimaging. Int. J. Pharm. 639, 122944. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.122944 (2023).","journal-title":"Int. J. Pharm."},{"key":"98102_CR41","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.3390\/molecules29102281","volume":"29","author":"GG Giannelli","year":"2024","unstructured":"Giannelli, G. G., Davidson, E., Pereira, J. & Santra, S. Design and development of a polymeric-based curcumin nanoparticle for drug delivery enhancement and potential incorporation into nerve conduits. Molecules 29, 2281. https:\/\/doi.org\/10.3390\/molecules29102281 (2024).","journal-title":"Molecules"},{"key":"98102_CR42","doi-asserted-by":"publisher","first-page":"3616","DOI":"10.1080\/07391102.2023.2220045","volume":"42","author":"P Nayana","year":"2023","unstructured":"Nayana, P. et al. A combined in vitro and molecular dynamics simulation studies unveil the molecular basis of the anticancer potential of piperine targeting AKT1 against prostate cancer. J. Biomol. Struct. Dyn. 42, 3616\u20133629. https:\/\/doi.org\/10.1080\/07391102.2023.2220045 (2023).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"98102_CR43","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jphotochemrev.2009.05.001","volume":"10","author":"KI Priyadarsini","year":"2009","unstructured":"Priyadarsini, K. I. Photophysics, photochemistry and photobiology of curcumin: Studies from organic solutions, bio-mimetics and living cells. J. Photochem. Photobiol., C 10, 81\u201395. https:\/\/doi.org\/10.1016\/j.jphotochemrev.2009.05.001 (2009).","journal-title":"J. Photochem. Photobiol., C"},{"key":"98102_CR44","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1002\/ptr.7764","volume":"37","author":"S Sharifi","year":"2023","unstructured":"Sharifi, S. et al. Efficacy of curcumin plus piperine co-supplementation in moderate-to-high hepatic steatosis: A double-blind, randomized, placebo-controlled clinical trial. Phytother Res 37, 2217\u20132229. https:\/\/doi.org\/10.1002\/ptr.7764 (2023).","journal-title":"Phytother Res"},{"key":"98102_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s12937-023-00905-1","author":"K Boshagh","year":"2023","unstructured":"Boshagh, K. et al. The effects of curcumin\u2013piperine supplementation on inflammatory, oxidative stress and metabolic indices in patients with ischemic stroke in the rehabilitation phase: A randomized controlled trial. Nutr. J. 22, 69. https:\/\/doi.org\/10.1186\/s12937-023-00905-1 (2023).","journal-title":"Nutr. J."},{"key":"98102_CR46","doi-asserted-by":"publisher","first-page":"5488","DOI":"10.3390\/cancers15225488","volume":"15","author":"S Benayad","year":"2023","unstructured":"Benayad, S. et al. The promise of piperine in cancer chemoprevention. Cancers 15, 5488. https:\/\/doi.org\/10.3390\/cancers15225488 (2023).","journal-title":"Cancers"},{"key":"98102_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2018.00010","author":"RA Rather","year":"2018","unstructured":"Rather, R. A. & Bhagat, M. Cancer chemoprevention and piperine: Molecular mechanisms and therapeutic opportunities. Front. Cell Dev. Biol. 6, 10. https:\/\/doi.org\/10.3389\/fcell.2018.00010 (2018).","journal-title":"Front. Cell Dev. Biol."},{"key":"98102_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.772418","author":"S Mitra","year":"2022","unstructured":"Mitra, S. et al. Anticancer applications and pharmacological properties of piperidine and piperine: A comprehensive review on molecular mechanisms and therapeutic perspectives. Front. Pharmacol. 12, 772418. https:\/\/doi.org\/10.3389\/fphar.2021.772418 (2022).","journal-title":"Front. Pharmacol."},{"key":"98102_CR49","doi-asserted-by":"publisher","DOI":"10.1177\/026119290503300618","author":"F Zucco","year":"2022","unstructured":"Zucco, F. et al. An inter-laboratory study to evaluate the effects of medium composition on the differentiation and barrier function of Caco-2 cell lines. Altern. Lab. Anim. 33, 603\u2013618. https:\/\/doi.org\/10.1177\/026119290503300618 (2005).","journal-title":"Altern. Lab. Anim."},{"key":"98102_CR50","doi-asserted-by":"publisher","first-page":"21555","DOI":"10.3390\/ijms160921555","volume":"16","author":"S Kamiloglu","year":"2015","unstructured":"Kamiloglu, S., Capanoglu, E., Grootaert, C. & Van Camp, J. Anthocyanin absorption and metabolism by human intestinal Caco-2 Cells\u2014a review. Int. J. Mol. Sci. 16, 21555\u201321574 (2015).","journal-title":"Int. J. Mol. Sci."},{"key":"98102_CR51","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ijpharm.2018.08.044","volume":"550","author":"MC Operti","year":"2018","unstructured":"Operti, M. C. et al. A comparative assessment of continuous production techniques to generate sub-micron size PLGA particles. Int. J. Pharm. 550, 140\u2013148. https:\/\/doi.org\/10.1016\/j.ijpharm.2018.08.044 (2018).","journal-title":"Int. J. Pharm."},{"key":"98102_CR52","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1021\/acsabm.8b00754","volume":"2","author":"E Swider","year":"2019","unstructured":"Swider, E. et al. F\u00f6rster resonance energy transfer-based stability assessment of PLGA nanoparticles in vitro and in vivo. ACS Appl. Bio Mater. 2, 1131\u20131140. https:\/\/doi.org\/10.1021\/acsabm.8b00754 (2019).","journal-title":"ACS Appl. Bio Mater."},{"key":"98102_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics11110590","author":"MC Operti","year":"2019","unstructured":"Operti, M. C. et al. Microfluidics-assisted size tuning and biological evaluation of PLGA particles. Pharmaceutics 11, 590. https:\/\/doi.org\/10.3390\/pharmaceutics11110590 (2019).","journal-title":"Pharmaceutics"},{"key":"98102_CR54","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.nano.2010.02.002","volume":"6","author":"B Semete","year":"2010","unstructured":"Semete, B. et al. In vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery systems. Nanomed. Nanotechnol. Biol. Med. 6, 662\u2013671. https:\/\/doi.org\/10.1016\/j.nano.2010.02.002 (2010).","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"98102_CR55","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1093\/humrep\/dem011","volume":"22","author":"S Al-Nasiry","year":"2007","unstructured":"Al-Nasiry, S., Geusens, N., Hanssens, M., Luyten, C. & Pijnenborg, R. The use of Alamar Blue assay for quantitative analysis of viability, migration and invasion of choriocarcinoma cells. Hum. Reprod. 22, 1304\u20131309. https:\/\/doi.org\/10.1093\/humrep\/dem011 (2007).","journal-title":"Hum. Reprod."},{"key":"98102_CR56","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/nnano.2007.387","volume":"2","author":"D Peer","year":"2007","unstructured":"Peer, D. et al. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2, 751\u2013760. https:\/\/doi.org\/10.1038\/nnano.2007.387 (2007).","journal-title":"Nat. Nanotechnol."},{"key":"98102_CR57","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.jnutbio.2013.10.002","volume":"25","author":"S Wang","year":"2014","unstructured":"Wang, S. et al. Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals. J. Nutr. Biochem. 25, 363\u2013376. https:\/\/doi.org\/10.1016\/j.jnutbio.2013.10.002 (2014).","journal-title":"J. Nutr. Biochem."},{"key":"98102_CR58","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s12263-009-0152-3","volume":"5","author":"M-H Teiten","year":"2010","unstructured":"Teiten, M.-H., Gaascht, F., Eifes, S., Dicato, M. & Diederich, M. Chemopreventive potential of curcumin in prostate cancer. Genes Nutr. 5, 61\u201374. https:\/\/doi.org\/10.1007\/s12263-009-0152-3 (2010).","journal-title":"Genes Nutr."},{"key":"98102_CR59","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/pros.1074","volume":"47","author":"T Dorai","year":"2001","unstructured":"Dorai, T., Cao, Y.-C., Dorai, B., Buttyan, R. & Katz, A. E. Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo. Prostate 47, 293\u2013303. https:\/\/doi.org\/10.1002\/pros.1074 (2001).","journal-title":"Prostate"},{"key":"98102_CR60","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.3390\/biom10111536","volume":"10","author":"D Termini","year":"2020","unstructured":"Termini, D., Den Hartogh, D. J., Jaglanian, A. & Tsiani, E. Curcumin against prostate cancer: Current evidence. Biomolecules 10, 1536. https:\/\/doi.org\/10.3390\/biom10111536 (2020).","journal-title":"Biomolecules"},{"key":"98102_CR61","doi-asserted-by":"publisher","first-page":"e65889","DOI":"10.1371\/journal.pone.0065889","volume":"8","author":"BO Williams","year":"2013","unstructured":"Williams, B. O. et al. Piperine, a bioactive component of pepper spice exerts therapeutic effects on androgen dependent and androgen independent prostate cancer cells. PLoS ONE 8, e65889. https:\/\/doi.org\/10.1371\/journal.pone.0065889 (2013).","journal-title":"PLoS ONE"},{"key":"98102_CR62","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.fct.2013.08.007","volume":"60","author":"D-Y Ouyang","year":"2013","unstructured":"Ouyang, D.-Y. et al. Piperine inhibits the proliferation of human prostate cancer cells via induction of cell cycle arrest and autophagy. Food Chem. Toxicol. 60, 424\u2013430. https:\/\/doi.org\/10.1016\/j.fct.2013.08.007 (2013).","journal-title":"Food Chem. Toxicol."},{"key":"98102_CR63","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ejphar.2007.07.056","volume":"575","author":"S Kumar","year":"2007","unstructured":"Kumar, S. et al. Piperine inhibits TNF-\u03b1 induced adhesion of neutrophils to endothelial monolayer through suppression of NF-\u03baB and I\u03baB kinase activation. Eur. J. Pharmacol. 575, 177\u2013186. https:\/\/doi.org\/10.1016\/j.ejphar.2007.07.056 (2007).","journal-title":"Eur. J. Pharmacol."},{"key":"98102_CR64","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0303-7207(94)90277-1","volume":"100","author":"WE Rainey","year":"1994","unstructured":"Rainey, W. E., Bird, I. M. & Mason, J. I. The NCI-H295 cell line: a pluripotent model for human adrenocortical studies. Mol. Cell. Endocrinol. 100, 45\u201350. https:\/\/doi.org\/10.1016\/0303-7207(94)90277-1 (1994).","journal-title":"Mol. Cell. Endocrinol."},{"key":"98102_CR65","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1210\/mend.7.3.8387159","volume":"7","author":"B Staels","year":"1993","unstructured":"Staels, B., Hum, D. W. & Miller, W. L. Regulation of steroidogenesis in NCI-H295 cells: A cellular model of the human fetal adrenal. Mol. Endocrinol. 7, 423\u2013433. https:\/\/doi.org\/10.1210\/mend.7.3.8387159 (1993).","journal-title":"Mol. Endocrinol."},{"key":"98102_CR66","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1210\/en.133.4.1555","volume":"133","author":"IM Bird","year":"1993","unstructured":"Bird, I. M. et al. Human NCI-H295 adrenocortical carcinoma cells: A model for angiotensin-II-responsive aldosterone secretion. Endocrinology 133, 1555\u20131561. https:\/\/doi.org\/10.1210\/en.133.4.1555 (1993).","journal-title":"Endocrinology"},{"key":"98102_CR67","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1007\/s40262-016-0403-6","volume":"55","author":"GE Benoist","year":"2016","unstructured":"Benoist, G. E. et al. Pharmacokinetic aspects of the two novel oral drugs used for metastatic castration-resistant prostate cancer: Abiraterone acetate enzalutamide. Clin. Pharmacokinet. 55, 1369 (2016).","journal-title":"Clin. Pharmacokinet."},{"key":"98102_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(12)70585-5","volume":"14","author":"TK Burki","year":"2013","unstructured":"Burki, T. K. Abiraterone and castration-resistant prostate cancer. Lancet Oncol. 14, e48. https:\/\/doi.org\/10.1016\/s1470-2045(12)70585-5 (2013).","journal-title":"Lancet Oncol."},{"key":"98102_CR69","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1161\/atvbaha.119.313046","volume":"40","author":"JR Hu","year":"2020","unstructured":"Hu, J. R. et al. Cardiovascular effects of androgen deprivation therapy in prostate cancer: Contemporary meta-analyses. Arterioscler. Thromb. Vasc. Biol. 40, e55\u2013e64. https:\/\/doi.org\/10.1161\/atvbaha.119.313046 (2020).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"98102_CR70","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.jsbmb.2017.09.007","volume":"174","author":"J Malikova","year":"2017","unstructured":"Malikova, J. et al. CYP17A1 inhibitor abiraterone, an anti-prostate cancer drug, also inhibits the 21-hydroxylase activity of CYP21A2. J. Steroid Biochem. Mol. Biol. 174, 192\u2013200. https:\/\/doi.org\/10.1016\/j.jsbmb.2017.09.007 (2017).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"98102_CR71","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1158\/1078-0432.ccr-14-1220","volume":"21","author":"EJ Chen","year":"2015","unstructured":"Chen, E. J. et al. Abiraterone treatment in castration-resistant prostate cancer selects for progesterone responsive mutant androgen receptors. Clin. Cancer Res. 21, 1273\u20131280. https:\/\/doi.org\/10.1158\/1078-0432.ccr-14-1220 (2015).","journal-title":"Clin. Cancer Res."},{"key":"98102_CR72","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1002\/pros.23799","volume":"79","author":"JM Moll","year":"2019","unstructured":"Moll, J. M. et al. A bypass mechanism of abiraterone-resistant prostate cancer: Accumulating CYP17A1 substrates activate androgen receptor signaling. Prostate 79, 937\u2013948. https:\/\/doi.org\/10.1002\/pros.23799 (2019).","journal-title":"Prostate"},{"key":"98102_CR73","doi-asserted-by":"publisher","DOI":"10.1080\/14756366.2025.2463014","author":"TM Wr\u00f3bel","year":"2025","unstructured":"Wr\u00f3bel, T. M. et al. Pyridine indole hybrids as novel potent CYP17A1 inhibitors. J. Enzyme Inhib. Med. Chem. 40, 2463014. https:\/\/doi.org\/10.1080\/14756366.2025.2463014 (2025).","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"98102_CR74","doi-asserted-by":"publisher","first-page":"13265","DOI":"10.1074\/jbc.M414673200","volume":"280","author":"AV Pandey","year":"2005","unstructured":"Pandey, A. V. & Miller, W. L. Regulation of 17,20 lyase activity by cytochrome b5 and by serine phosphorylation of P450c17. J. Biol. Chem. 280, 13265\u201313271. https:\/\/doi.org\/10.1074\/jbc.M414673200 (2005).","journal-title":"J. Biol. Chem."},{"key":"98102_CR75","doi-asserted-by":"publisher","first-page":"931089","DOI":"10.3389\/fphar.2022.931089","volume":"13","author":"MJ Prado","year":"2022","unstructured":"Prado, M. J., Ligabue-Braun, R., Zaha, A., Rossetti, M. L. R. & Pandey, A. V. Variant predictions in congenital adrenal hyperplasia caused by mutations in CYP21A2. Front. Pharmacol. 13, 931089. https:\/\/doi.org\/10.3389\/fphar.2022.931089 (2022).","journal-title":"Front. Pharmacol."},{"key":"98102_CR76","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23010296","author":"MJ Prado","year":"2021","unstructured":"Prado, M. J. et al. Characterization of mutations causing CYP21A2 deficiency in Brazilian and Portuguese populations. Int. J. Mol. Sci. 23, 296. https:\/\/doi.org\/10.3390\/ijms23010296 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"98102_CR77","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jsbmb.2016.04.021","volume":"163","author":"IM Bird","year":"2016","unstructured":"Bird, I. M. & Abbott, D. H. The hunt for a selective 17,20 lyase inhibitor: Learning lessons from nature. J. Steroid Biochem. Mol. Biol. 163, 136\u2013146. https:\/\/doi.org\/10.1016\/j.jsbmb.2016.04.021 (2016).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"98102_CR78","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.pharmthera.2013.01.010","volume":"138","author":"AV Pandey","year":"2013","unstructured":"Pandey, A. V. & Fl\u00fcck, C. E. NADPH P450 oxidoreductase: Structure, function, and pathology of diseases. Pharmacol. Ther. 138, 229\u2013254. https:\/\/doi.org\/10.1016\/j.pharmthera.2013.01.010 (2013).","journal-title":"Pharmacol. Ther."},{"key":"98102_CR79","doi-asserted-by":"publisher","first-page":"e574","DOI":"10.1210\/clinem\/dgae815","volume":"110","author":"WL Miller","year":"2025","unstructured":"Miller, W. L., Pandey, A. V. & Fl\u00fcck, C. E. Disordered electron transfer: New forms of defective steroidogenesis and mitochondriopathy. J. Clin. Endocrinol. Metab. 110, e574\u2013e582. https:\/\/doi.org\/10.1210\/clinem\/dgae815 (2025).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"98102_CR80","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2014.00103","author":"AV Pandey","year":"2014","unstructured":"Pandey, A. V. & Sproll, P. Pharmacogenomics of human P450 oxidoreductase. Front. Pharmacol. 5, 103. https:\/\/doi.org\/10.3389\/fphar.2014.00103 (2014).","journal-title":"Front. Pharmacol."},{"key":"98102_CR81","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1038\/s41467-021-22562-w","volume":"12","author":"SB Jensen","year":"2021","unstructured":"Jensen, S. B. et al. Biased cytochrome P450-mediated metabolism via small-molecule ligands binding P450 oxidoreductase. Nat. Commun. 12, 2260. https:\/\/doi.org\/10.1038\/s41467-021-22562-w (2021).","journal-title":"Nat. Commun."},{"key":"98102_CR82","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3390\/cancers16030523","volume":"16","author":"S Maekawa","year":"2024","unstructured":"Maekawa, S., Takata, R. & Obara, W. Molecular mechanisms of prostate cancer development in the precision medicine era: A comprehensive review. Cancers 16, 523. https:\/\/doi.org\/10.3390\/cancers16030523 (2024).","journal-title":"Cancers"},{"key":"98102_CR83","doi-asserted-by":"publisher","first-page":"102654","DOI":"10.1016\/j.jbc.2022.102654","volume":"298","author":"R Hall","year":"2022","unstructured":"Hall, R., Yuan, S., Wood, K., Katona, M. & Straub, A. C. Cytochrome b5 reductases: Redox regulators of cell homeostasis. J. Biol. Chem. 298, 102654. https:\/\/doi.org\/10.1016\/j.jbc.2022.102654 (2022).","journal-title":"J. Biol. Chem."},{"key":"98102_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05053-8","author":"H Guo","year":"2022","unstructured":"Guo, H. et al. Cytochrome B5 type A alleviates HCC metastasis via regulating STOML2 related autophagy and promoting sensitivity to ruxolitinib. Cell Death Dis. 13, 623. https:\/\/doi.org\/10.1038\/s41419-022-05053-8 (2022).","journal-title":"Cell Death Dis."},{"key":"98102_CR85","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.3390\/biom13121728","volume":"13","author":"MN Rojas Velazquez","year":"2023","unstructured":"Rojas Velazquez, M. N., Therkelsen, S. & Pandey, A. V. Exploring novel variants of the cytochrome P450 reductase gene (POR) from the genome aggregation database by integrating bioinformatic tools and functional assays. Biomolecules 13, 1728. https:\/\/doi.org\/10.3390\/biom13121728 (2023).","journal-title":"Biomolecules"},{"key":"98102_CR86","doi-asserted-by":"publisher","first-page":"10141","DOI":"10.3390\/ijms231710141","volume":"23","author":"MN Rojas Velazquez","year":"2022","unstructured":"Rojas Velazquez, M. N., Noebauer, M. & Pandey, A. V. Loss of protein stability and function caused by P228L variation in NADPH-cytochrome P450 reductase linked to lower testosterone levels. Int. J. Mol. Sci. 23, 10141. https:\/\/doi.org\/10.3390\/ijms231710141 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"98102_CR87","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa076","author":"S Parween","year":"2020","unstructured":"Parween, S. et al. Molecular basis of CYP19A1 deficiency in a 46, XX patient with R550W mutation in POR: Expanding the PORD phenotype. J. Clin. Endocrinol. Metab. 105, dgaa076. https:\/\/doi.org\/10.1210\/clinem\/dgaa076 (2020).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"98102_CR88","doi-asserted-by":"publisher","first-page":"105507","DOI":"10.1016\/j.jsbmb.2019.105507","volume":"196","author":"S Parween","year":"2020","unstructured":"Parween, S. et al. Differential effects of variations in human P450 oxidoreductase on the aromatase activity of CYP19A1 polymorphisms R264C and R264H. J. Steroid Biochem. Mol. Biol. 196, 105507. https:\/\/doi.org\/10.1016\/j.jsbmb.2019.105507 (2020).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"98102_CR89","doi-asserted-by":"publisher","first-page":"14632","DOI":"10.1073\/pnas.2003154117","volume":"117","author":"CE Fluck","year":"2020","unstructured":"Fluck, C. E., Parween, S., Rojas Velazquez, M. N. & Pandey, A. V. Inhibition of placental CYP19A1 activity remains as a valid hypothesis for 46, XX virilization in P450 oxidoreductase deficiency. Proc. Natl. Acad. Sci. U. S. A. 117, 14632\u201314633. https:\/\/doi.org\/10.1073\/pnas.2003154117 (2020).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"98102_CR90","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.bbrc.2019.05.127","volume":"515","author":"MNR Velazquez","year":"2019","unstructured":"Velazquez, M. N. R., Parween, S., Udhane, S. S. & Pandey, A. V. Variability in human drug metabolizing cytochrome P450 CYP2C9, CYP2C19 and CYP3A5 activities caused by genetic variations in cytochrome P450 oxidoreductase. Biochem. Biophys. Res. Commun. 515, 133\u2013138. https:\/\/doi.org\/10.1016\/j.bbrc.2019.05.127 (2019).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"98102_CR91","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01187","author":"S Parween","year":"2019","unstructured":"Parween, S., Rojas Velazquez, M. N., Udhane, S. S., Kagawa, N. & Pandey, A. V. Variability in loss of multiple enzyme activities due to the human genetic variation P284T located in the flexible hinge region of NADPH cytochrome P450 oxidoreductase. Front. Pharmacol. 10, 1187. https:\/\/doi.org\/10.3389\/fphar.2019.01187 (2019).","journal-title":"Front. Pharmacol."},{"key":"98102_CR92","doi-asserted-by":"publisher","first-page":"679","DOI":"10.3390\/nu12030679","volume":"12","author":"NA Abd. Wahab","year":"2020","unstructured":"Abd. Wahab, N. A., Lajis, N. H., Abas, F., Othman, I. & Naidu, R. Mechanism of anti-cancer activity of curcumin on androgen-dependent and androgen-independent prostate cancer. Nutrients 12, 679. https:\/\/doi.org\/10.3390\/nu12030679 (2020).","journal-title":"Nutrients"},{"key":"98102_CR93","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3390\/biom14020203","volume":"14","author":"K Sharma","year":"2024","unstructured":"Sharma, K. et al. Effect of essential oil components on the activity of steroidogenic cytochrome P450. Biomolecules 14, 203. https:\/\/doi.org\/10.3390\/biom14020203 (2024).","journal-title":"Biomolecules"},{"key":"98102_CR94","doi-asserted-by":"publisher","first-page":"8913","DOI":"10.1021\/acsapm.2c01316","volume":"4","author":"S Ben-Zichri","year":"2022","unstructured":"Ben-Zichri, S. et al. Synergistic activity of anticancer polyphenols embedded in amphiphilic dendrimer nanoparticles. ACS Appl. Polym. Mater. 4, 8913\u20138925. https:\/\/doi.org\/10.1021\/acsapm.2c01316 (2022).","journal-title":"ACS Appl. Polym. Mater."},{"key":"98102_CR95","doi-asserted-by":"publisher","first-page":"6036","DOI":"10.1021\/acsbiomaterials.9b01240","volume":"5","author":"S Sunoqrot","year":"2019","unstructured":"Sunoqrot, S. et al. Bioinspired polymerization of quercetin to produce a curcumin-loaded nanomedicine with potent cytotoxicity and cancer-targeting potential in vivo. ACS Biomater. Sci. Eng. 5, 6036\u20136045. https:\/\/doi.org\/10.1021\/acsbiomaterials.9b01240 (2019).","journal-title":"ACS Biomater. Sci. Eng."},{"key":"98102_CR96","doi-asserted-by":"publisher","first-page":"12362","DOI":"10.3390\/ijms232012362","volume":"23","author":"X-H Do","year":"2022","unstructured":"Do, X.-H. et al. Differential cytotoxicity of curcumin-loaded micelles on human tumor and stromal cells. Int. J. Mol. Sci. 23, 12362.\u00a0https:\/\/doi.org\/10.3390\/ijms232012362 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"98102_CR97","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.4161\/cbt.10.10.13250","volume":"10","author":"A Dayton","year":"2014","unstructured":"Dayton, A. et al. Cellular uptake, retention and bioabsorption of HO-3867, a fluorinated curcumin analog with potential antitumor properties. Cancer Biol. Ther. 10, 1027\u20131032. https:\/\/doi.org\/10.4161\/cbt.10.10.13250 (2014).","journal-title":"Cancer Biol. Ther."},{"key":"98102_CR98","doi-asserted-by":"publisher","DOI":"10.1055\/s-0028-1084679","author":"M Fronza","year":"2008","unstructured":"Fronza, M. et al. The scratch assay: A suitable in vitro tool for studying wound healing effects. Planta Med. 74, PD4. https:\/\/doi.org\/10.1055\/s-0028-1084679 (2008).","journal-title":"Planta Med."},{"key":"98102_CR99","doi-asserted-by":"publisher","first-page":"7461","DOI":"10.1007\/s00216-022-03881-3","volume":"414","author":"T Andrieu","year":"2022","unstructured":"Andrieu, T., du Toit, T., Vogt, B., Mueller, M. D. & Groessl, M. Parallel targeted and non-targeted quantitative analysis of steroids in human serum and peritoneal fluid by liquid chromatography high-resolution mass spectrometry. Anal. Bioanal. Chem. 414, 7461\u20137472. https:\/\/doi.org\/10.1007\/s00216-022-03881-3 (2022).","journal-title":"Anal. Bioanal. Chem."},{"key":"98102_CR100","doi-asserted-by":"publisher","DOI":"10.1159\/000545063","author":"EM Altinkilic","year":"2025","unstructured":"Altinkilic, E. M. et al. Fertility in non-classic lipoid CAH\u2014a case report and review of the literature. Hormone Res. Paediatr. https:\/\/doi.org\/10.1159\/000545063 (2025).","journal-title":"Hormone Res. Paediatr."},{"key":"98102_CR101","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.179071","author":"E Pignatti","year":"2024","unstructured":"Pignatti, E. et al. FDXR variants cause adrenal insufficiency and atypical sexual development. JCI Insight\u00a09, e179071. https:\/\/doi.org\/10.1172\/jci.insight.179071 (2024).","journal-title":"JCI Insight"},{"key":"98102_CR102","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/ejendo\/lvae090","volume":"191","author":"C Brachet","year":"2024","unstructured":"Brachet, C. et al. Insight into the role of TXNRD2 in steroidogenesis through a novel homozygous TXNRD2 splice variant. Eur. J. Endocrinol. 191, 144\u2013155. https:\/\/doi.org\/10.1093\/ejendo\/lvae090 (2024).","journal-title":"Eur. J. Endocrinol."},{"key":"98102_CR103","doi-asserted-by":"publisher","DOI":"10.3390\/biom13091349","author":"TM Wrobel","year":"2023","unstructured":"Wrobel, T. M. et al. Exploring the potential of sulfur moieties in compounds inhibiting steroidogenesis. Biomolecules 13, 1349. https:\/\/doi.org\/10.3390\/biom13091349 (2023).","journal-title":"Biomolecules"},{"key":"98102_CR104","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.bbrc.2016.07.019","volume":"477","author":"SS Udhane","year":"2016","unstructured":"Udhane, S. S., Dick, B., Hu, Q., Hartmann, R. W. & Pandey, A. V. Specificity of anti-prostate cancer CYP17A1 inhibitors on androgen biosynthesis. Biochem. Biophys. Res. Commun. 477, 1005\u20131010.\u00a0https:\/\/doi.org\/10.1016\/j.bbrc.2016.07.019 (2016).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"98102_CR105","doi-asserted-by":"publisher","DOI":"10.1038\/srep10132","author":"SS Udhane","year":"2015","unstructured":"Udhane, S. S., Pandey, A. V., Hofer, G., Mullis, P. E. & Fl\u00fcck, C. E. Retinoic acid receptor beta and angiopoietin-like protein 1 are involved in the regulation of human androgen biosynthesis. Sci. Rep. 5, 10132. https:\/\/doi.org\/10.1038\/srep10132 (2015).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98102-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98102-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98102-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T12:56:03Z","timestamp":1745067363000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98102-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,19]]},"references-count":105,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["98102"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-98102-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5326002\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.1101\/2024.10.24.620019","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,19]]},"assertion":[{"value":"24 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13613"}}